Alpha Particle Therapy of Solid Tumours [ 2018 - 2020 ]

Research Grant

Researchers: Prof Andrew Scott (Principal investigator) ,  A/Pr Hui Gan ,  A/Pr Paul Donnelly ,  A/Pr Uwe Ackermann ,  Dr Graeme O'Keefe
View all 7 related researchers

Brief description Alpha-particles linked to recombinant antibodies targeting tumour cells have potential to effectively treat tumours while minimising normal tissue side effects. We will explore a novel alpha-particle therapy approach to solid tumours, by delivering 225Ac directly into tumour cells, or into cells that support the tumour (microenvironment). This approach will hopefully result in development of a new approach to treatment of cancers that are resistant to conventional therapies.

Funding Amount $AUD 725,015.07

Funding Scheme Project Grants

Notes Standard Project Grant